“…With regard to these approaches, many prognostic studies for outcomes after UCBT have been performed, analysing factors related to patients, disease, donor and transplantation (Gluckman et al , 1997; Rubinstein et al , 1998; Wagner et al , 2002; Laughlin et al , 2001; Sanz et al , 2001; Gluckman et al 2004; Arcese et al 2006; Kurtzberg et al 2008). Variable factors have been identified, such as HLA, cell dose and others related to the choice of graft or factors related to the conditioning regimen (Nabhan et al , 2008) or GVHD prophylaxis (Locatelli et al , 2003).…”